{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:18:11Z","timestamp":1793823491080,"version":"4.6.1"},"reference-count":176,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"KRANIOPHARYNGEOM"},{"name":"German Childhood Cancer Foundation, Bonn, Germany","award":["DKS2014.13"],"award-info":[{"award-number":["DKS2014.13"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The hypothalamus is the key regulator of human energy balance. Hypothalamic dysfunction leads to (morbid) hypothalamic obesity, but may have many more consequences such as hypopituitarism, adipsia, disruption of the circadian rhythm, decreased energy expenditure, low core body temperature, and behavioral changes. Many patients with hypothalamic dysfunction experience chronic fatigue, increased daytime sleepiness, headaches, inactivity, and mood disorders, all of which may contribute to the development of obesity. Adipsic arginine vasopressin deficiency, severe hypothermia, uncontrollable hyperphagia, and severe mood disorders may require 24\/7 management. Signs and symptoms may be severe or mild. Severe hypothalamic dysfunction is usually readily diagnosed, but less severe hypothalamic dysfunction is much harder to recognize because, among other things, of its multifaceted presentation. Through raising awareness and by better categorization of the different clinical signs and symptoms of hypothalamic dysfunction within different domains, the underlying cause for fatigue and obesity observed in patients with hypothalamic dysfunction may be better understood, which in turn, will open new perspectives on successful management options. In this review, the state of the art for diagnostics and management of acquired hypothalamic dysfunction is summarized and a new management algorithm is suggested. The lessons learned from pediatric patients with acquired hypothalamic dysfunction, including hypothalamic obesity management through the different clinical domains, may also prove to be useful for patients with congenital or genetic forms of hypothalamic dysfunction resulting in fatigue and obesity, as well as for children with presumed \u201ccommon\u201d obesity.<\/jats:p>","DOI":"10.1210\/endrev\/bnaf025","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T11:37:49Z","timestamp":1753961869000},"page":"891-907","source":"Crossref","is-referenced-by-count":22,"title":["Management of Acquired Hypothalamic Dysfunction and the Hypothalamic Syndrome; It Is More Than Obesity"],"prefix":"10.1210","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6773-6931","authenticated-orcid":false,"given":"Hanneke M","family":"van Santen","sequence":"first","affiliation":[{"name":"Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, UMC Utrecht , Utrecht 3508XB ,","place":["the Netherlands"]},{"name":"Princess M\u00e1xima Center for Pediatric Oncology , Heidelberglaan 25, Utrecht 3584CS ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann L","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Pediatric Hematology\/Oncology, University Children's Hospital, Klinikum Oldenburg A\u00f6R , Oldenburg 26133 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"2025112318515429600_bnaf025-B1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/B978-0-12-819975-6.00031-5","article-title":"History of hypothalamic research: \u201cthe spring of primitive existence\u201d","volume":"179","author":"Kreier","year":"2021","journal-title":"Handb Clin Neurol"},{"key":"2025112318515429600_bnaf025-B2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41574-024-01036-1","article-title":"Control of tuberal hypothalamic development and its implications in metabolic disorders","volume":"21","author":"Placzek","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2025112318515429600_bnaf025-B3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1210\/er.2018-00017","article-title":"Pathophysiology and individualized treatment of hypothalamic obesity following craniopharyngioma and other suprasellar tumors: a systematic review","volume":"40","author":"Van Iersel","year":"2018","journal-title":"Endocr Rev"},{"key":"2025112318515429600_bnaf025-B4","doi-asserted-by":"crossref","first-page":"100174","DOI":"10.1016\/j.ejcped.2024.100174","article-title":"Fatigue in patients with hypothalamic syndrome\u2014a cross-sectional analysis of the German childhood-onset craniopharyngioma cohort","volume":"4","author":"Beckhaus","year":"2024","journal-title":"EJC Paediatr Oncol"},{"key":"2025112318515429600_bnaf025-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/519607","article-title":"Increased daytime sleepiness in patients with childhood craniopharyngioma and hypothalamic tumor involvement: review of the literature and perspectives","volume":"2010","author":"M\u00fcller","year":"2010","journal-title":"Int J Endocrinol"},{"issue":"6","key":"2025112318515429600_bnaf025-B6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/EJE-15-0709","article-title":"History before diagnosis in childhood craniopharyngioma: associations with initial presentation and long-term prognosis","volume":"173","author":"Hoffmann","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2025112318515429600_bnaf025-B7","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1210\/jc.2002-021797","article-title":"Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity","volume":"88","author":"Harz","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025112318515429600_bnaf025-B8","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jpeds.2013.12.010","article-title":"Neuropsychological outcome in patients with childhood craniopharyngioma and hypothalamic involvement","volume":"164","author":"\u00d6zyurt","year":"2014","journal-title":"J Pediatr"},{"key":"2025112318515429600_bnaf025-B9","doi-asserted-by":"crossref","first-page":"e230147","DOI":"10.1530\/EC-23-0147","article-title":"Acquired hypothalamic dysfunction in childhood: \u201cwhat do patients need?\u201d\u2014an endo-ERN survey","volume":"12","author":"van Roessel","year":"2023","journal-title":"Endocr Connect"},{"issue":"1","key":"2025112318515429600_bnaf025-B10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/ejendo\/lvae084","article-title":"Central diabetes insipidus (vasopressin deficiency) after surgery for pituitary tumours: a systematic review and meta-analysis","volume":"191","author":"Fountas","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025112318515429600_bnaf025-B11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s12276-022-00741-z","article-title":"Hypothalamic control of energy expenditure and thermogenesis","volume":"54","author":"Tran","year":"2022","journal-title":"Exp Mol Med"},{"issue":"S1","key":"2025112318515429600_bnaf025-B12","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/oby.20646","article-title":"Hyperphagia: current concepts and future directions proceedings of the 2nd international conference on hyperphagia","volume":"22","author":"Heymsfield","year":"2014","journal-title":"Obesity"},{"key":"2025112318515429600_bnaf025-B13","author":"Pop","year":"2021"},{"issue":"8","key":"2025112318515429600_bnaf025-B14","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/jne.12051","article-title":"Physiological regulation of magnocellular neurosecretory cell activity: integration of intrinsic, local and afferent mechanisms","volume":"25","author":"Brown","year":"2013","journal-title":"J Neuroendocrinol"},{"issue":"3","key":"2025112318515429600_bnaf025-B15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/endrev\/bnad033","article-title":"Appetite- and weight-regulating neuroendocrine circuitry in hypothalamic obesity","volume":"45","author":"Gan","year":"2024","journal-title":"Endocr Rev"},{"issue":"8","key":"2025112318515429600_bnaf025-B16","doi-asserted-by":"crossref","first-page":"e220276","DOI":"10.1530\/EC-22-0276","article-title":"Resting energy expenditure in children at risk of hypothalamic dysfunction","volume":"11","author":"Van Schaik","year":"2022","journal-title":"Endocr Connect"},{"issue":"19","key":"2025112318515429600_bnaf025-B17","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.3390\/jcm13195993","article-title":"Resting energy expenditure in patients with extreme obesity: comparison of the harris-benedict equation with indirect calorimetry","volume":"13","author":"J\u00edlkov\u00e1","year":"2024  8","journal-title":"J Clin Med"},{"issue":"4","key":"2025112318515429600_bnaf025-B18","first-page":"295","article-title":"Physical activity, health-related fitness, and physical performance in children with acquired hypothalamic dysfunction","volume":"33","author":"Van Roessel","year":"2025","journal-title":"Support Care Cancer"},{"issue":"1","key":"2025112318515429600_bnaf025-B19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-022-00351-z","article-title":"Hypothalamic syndrome","volume":"8","author":"M\u00fcller","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"2025112318515429600_bnaf025-B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/clinem\/dgac547","article-title":"Changing the name of diabetes insipidus: a position statement of the working group for renaming diabetes insipidus","volume":"108","author":"Arima","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2025112318515429600_bnaf025-B21","doi-asserted-by":"crossref","first-page":"e13317","DOI":"10.1111\/jne.13317","article-title":"Elevated IGF-1 concentrations in children with low grade glioma: a descriptive analysis in a retrospective national cohort","volume":"35","author":"van Schaik","year":"2023","journal-title":"J Neuroendocrinol"},{"issue":"8","key":"2025112318515429600_bnaf025-B22","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1210\/jcem.87.8.8751","article-title":"Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients","volume":"87","author":"M\u00fcller","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025112318515429600_bnaf025-B23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1188\/09.ONF.723-731","article-title":"Factors associated with sleep-wake disturbances in child and adult survivors of pediatric brain tumors: a review","volume":"36","author":"Gapstur","year":"2009","journal-title":"Oncol Nurs Forum"},{"key":"2025112318515429600_bnaf025-B24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.autneu.2017.08.006","article-title":"Site and type of craniopharyngiomas impact differently on 24-hour circadian rhythms and surgical outcome. A neurophysiological evaluation","volume":"208","author":"Foschi","year":"2017","journal-title":"Auton Neurosci"},{"key":"2025112318515429600_bnaf025-B25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s11102-020-01065-9","article-title":"The importance of specialized sleep investigations in children with a suprasellar tumor","volume":"23","author":"van Schaik","year":"2020","journal-title":"Pituitary"},{"issue":"4","key":"2025112318515429600_bnaf025-B26","first-page":"435","article-title":"Secondary narcolepsy in children with brain tumors","volume":"25","author":"Marcus","year":"2002","journal-title":"Sleep"},{"key":"2025112318515429600_bnaf025-B27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neures.2017.03.013","article-title":"Hypothalamic regulation of the sleep\/wake cycle","volume":"118","author":"Ono","year":"2017","journal-title":"Neurosci Res"},{"issue":"10","key":"2025112318515429600_bnaf025-B28","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1523\/JNEUROSCI.20-10-03830.2000","article-title":"Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep","volume":"20","author":"Lu","year":"2000","journal-title":"J Neurosci"},{"issue":"Suppl 1","key":"2025112318515429600_bnaf025-B29","first-page":"423","article-title":"Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese childhood craniopharyngioma patients","volume":"19","author":"M\u00fcller","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"2025112318515429600_bnaf025-B30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/ejendo\/lvad009","article-title":"Diagnostic criteria for the hypothalamic syndrome in childhood","volume":"188","author":"van Santen","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"2025112318515429600_bnaf025-B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103313","article-title":"The many different clinical faces of acquired hypothalamic dysfunction: a retrospective cohort study in the Netherlands.","volume":"85","author":"van Roessel IMAA, Hulsmann SC, Schouten-van Meeteren AYN","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"1","key":"2025112318515429600_bnaf025-B32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11060-018-2936-z","article-title":"Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma","volume":"140","author":"Mehren","year":"2018","journal-title":"J Neurooncol"},{"issue":"1","key":"2025112318515429600_bnaf025-B33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11060-015-1885-z","article-title":"A systematic review of cognitive performance in patients with childhood craniopharyngioma","volume":"125","author":"\u00d6zyurt","year":"2015","journal-title":"J Neurooncol"},{"issue":"Suppl. 1","key":"2025112318515429600_bnaf025-B34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000053201","article-title":"Molecular genetics of septo-optic dysplasia","volume":"53","author":"Dattani","year":"2000","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"2025112318515429600_bnaf025-B35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S2213-8587(21)00002-4","article-title":"Endocrine disorders in prader-willi syndrome: a model to understand and treat hypothalamic dysfunction","volume":"9","author":"Tauber","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025112318515429600_bnaf025-B36","doi-asserted-by":"crossref","first-page":"846124","DOI":"10.3389\/fendo.2022.846124","article-title":"Transition from diencephalic syndrome to hypothalamic obesity in children with suprasellar low grade glioma: a case series","volume":"13","author":"van Roessel","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2025112318515429600_bnaf025-B37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/MOP.0b013e3281ab6eeb","article-title":"The effects of head trauma on hypothalamic\u2013pituitary function in children and adolescents","volume":"19","author":"Einaudi","year":"2007","journal-title":"Curr Opin Pediatr"},{"key":"2025112318515429600_bnaf025-B38","first-page":"1","article-title":"Rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, and neuroendocrine tumors (ROHHADNET) syndrome: a systematic review","volume":"2018","author":"Lee","year":"2018","journal-title":"Biomed Res Int"},{"key":"2025112318515429600_bnaf025-B39","author":"van Schaik"},{"issue":"12","key":"2025112318515429600_bnaf025-B40","doi-asserted-by":"crossref","first-page":"e13439","DOI":"10.1111\/jne.13439","article-title":"Hypothalamic obesity: epidemiology in rare sellar\/suprasellar tumors\u2014a German claims database analysis","volume":"36","author":"Witte","year":"2024","journal-title":"J Neuroendocrinol"},{"key":"2025112318515429600_bnaf025-B41","volume-title":"Central Nervous System Tumours [Internet]","author":"Santagata","year":"2021","edition":"5th ed."},{"issue":"6","key":"2025112318515429600_bnaf025-B42","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/nan.12226","article-title":"Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma","volume":"41","author":"Martinez-Barbera","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1-2","key":"2025112318515429600_bnaf025-B43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1515\/jpem-2014-0442","article-title":"Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models","volume":"28","author":"Martinez-Barbera","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"9-10","key":"2025112318515429600_bnaf025-B44","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1159\/000506904","article-title":"Biological behaviour of craniopharyngiomas","volume":"110","author":"Martinez-Barbera","year":"2020","journal-title":"Neuroendocrinology"},{"issue":"1","key":"2025112318515429600_bnaf025-B45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11060-016-2160-7","article-title":"First report on spinal metastasis in childhood-onset craniopharyngioma","volume":"129","author":"Hoffmann","year":"2016","journal-title":"J Neurooncol"},{"key":"2025112318515429600_bnaf025-B46","first-page":"e69607","article-title":"Ectopic craniopharyngioma recurrence: a case report and literature review","volume":"16","author":"Nogueira","year":"2024","journal-title":"Cureus"},{"issue":"3","key":"2025112318515429600_bnaf025-B47","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-0031-1273743","article-title":"Ectopic craniopharyngioma","volume":"223","author":"Kordes","year":"2011","journal-title":"Klin Padiatr"},{"key":"2025112318515429600_bnaf025-B48","doi-asserted-by":"crossref","first-page":"1401761","DOI":"10.3389\/fonc.2024.1401761","article-title":"Feasibility, tolerability, and first experience of intracystic treatment with peginterferon alfa-2a in patients with cystic craniopharyngioma","volume":"14","author":"Hedrich","year":"2024","journal-title":"Front Oncol"},{"issue":"4","key":"2025112318515429600_bnaf025-B49","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/2010.1.FOCUS09310","article-title":"Craniopharyngiomas: intratumoral chemotherapy with interferon-\u03b1: a multicenter preliminary study with 60 cases","volume":"28","author":"Cavalheiro","year":"2010","journal-title":"Neurosurg Focus"},{"issue":"10","key":"2025112318515429600_bnaf025-B50","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/neuonc\/nox056","article-title":"Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN","volume":"19","author":"Kilday","year":"2017","journal-title":"Neuro Oncol"},{"issue":"2","key":"2025112318515429600_bnaf025-B51","doi-asserted-by":"crossref","first-page":"CASE24410","DOI":"10.3171\/CASE24410","article-title":"Recurrent adamantinomatous craniopharyngioma stabilized with tocilizumab and bevacizumab: illustrative case","volume":"9","author":"Webb","year":"2025","journal-title":"J Neurosurg Case Lessons"},{"key":"2025112318515429600_bnaf025-B52","doi-asserted-by":"crossref","first-page":"1225734","DOI":"10.3389\/fendo.2023.1225734","article-title":"Tocilizumab for the fifth progression of cystic childhood craniopharyngioma\u2014a case report","volume":"14","author":"de Vos-Kerkhof","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025112318515429600_bnaf025-B53","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3389\/fonc.2019.00791","article-title":"Targeting IL-6 is a potential treatment for primary cystic craniopharyngioma","volume":"9","author":"Grob","year":"2019","journal-title":"Front Oncol"},{"issue":"5","key":"2025112318515429600_bnaf025-B54","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1530\/EC-19-0074","article-title":"Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma","volume":"8","author":"Bogusz","year":"2019","journal-title":"Endocr Connect"},{"issue":"2","key":"2025112318515429600_bnaf025-B55","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00381-005-1192-7","article-title":"More or less? Treatment strategies in childhood craniopharyngioma","volume":"22","author":"M\u00fcller","year":"2006","journal-title":"Child's Nervous System"},{"issue":"3","key":"2025112318515429600_bnaf025-B56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-0034-1368785","article-title":"Childhood craniopharyngioma\u2014changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000\/2007","volume":"226","author":"Hoffmann","year":"2014","journal-title":"Klin Padiatr"},{"issue":"6","key":"2025112318515429600_bnaf025-B57","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/jc.2012-3928","article-title":"Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity","volume":"98","author":"Elowe-Gruau","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2025112318515429600_bnaf025-B58","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/neuonc\/nov044","article-title":"Survival, hypothalamic obesity, and neuropsychological\/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes","volume":"17","author":"Sterkenburg","year":"2015","journal-title":"Neuro Oncol"},{"issue":"10","key":"2025112318515429600_bnaf025-B59","doi-asserted-by":"crossref","first-page":"e0240016","DOI":"10.1371\/journal.pone.0240016","article-title":"Visual functions in children with craniopharyngioma at diagnosis: a systematic review","volume":"15","author":"Nuijts","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"2025112318515429600_bnaf025-B60","doi-asserted-by":"crossref","first-page":"19599","DOI":"10.1038\/s41598-023-46532-y","article-title":"Vision-related quality of life in patients with childhood-onset craniopharyngioma","volume":"13","author":"Sowithayasakul","year":"2023","journal-title":"Sci Rep"},{"issue":"3","key":"2025112318515429600_bnaf025-B61","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/ejendo\/lvad027","article-title":"Outcome after pediatric craniopharyngioma: the role of age at diagnosis and hypothalamic damage","volume":"188","author":"Beckhaus","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2025112318515429600_bnaf025-B62","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1210\/jc.2003-031751","article-title":"Longitudinal study on growth and body mass Index before and after diagnosis of childhood craniopharyngioma","volume":"89","author":"M\u00fcller","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025112318515429600_bnaf025-B63","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-2001-16855","article-title":"Obesity after childhood craniopharyngioma\u2014german multicenter study on pre-operative risk factors and quality of life","volume":"213","author":"M\u00fcller","year":"2001","journal-title":"Klin Padiatr"},{"issue":"6","key":"2025112318515429600_bnaf025-B64","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nrc3069","article-title":"Assessing the risk of second malignancies after modern radiotherapy","volume":"11","author":"Newhauser","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"2025112318515429600_bnaf025-B65","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3390\/cancers16061099","article-title":"Vascular morbidity and mortality in craniopharyngioma patients\u2014a scoping review","volume":"16","author":"Beckhaus","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2025112318515429600_bnaf025-B66","doi-asserted-by":"crossref","first-page":"698150","DOI":"10.3389\/fonc.2021.698150","article-title":"Cerebral infarction in childhood-onset craniopharyngioma patients: results of KRANIOPHARYNGEOM 2007","volume":"11","author":"Boekhoff","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"2025112318515429600_bnaf025-B67","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijrobp.2021.12.172","article-title":"Pre- and posttherapy risk factors for vasculopathy in pediatric patients with craniopharyngioma treated with surgery and proton radiation therapy","volume":"113","author":"Lucas","year":"2022","journal-title":"Int J Radiation Oncol Biol Phys"},{"issue":"1","key":"2025112318515429600_bnaf025-B68","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40478-020-00902-z","article-title":"Pediatric low-grade glioma in the era of molecular diagnostics","volume":"8","author":"Ryall","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"2025112318515429600_bnaf025-B69","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11060-013-1284-2","article-title":"Favorable survival and metabolic outcome for children with diencephalic syndrome using a radiation-sparing approach","volume":"116","author":"Kilday","year":"2014","journal-title":"J Neurooncol"},{"issue":"10","key":"2025112318515429600_bnaf025-B70","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/neuonc\/nos202","article-title":"Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German speaking society of pediatric oncology and hematology","volume":"14","author":"Gnekow","year":"2012","journal-title":"Neuro Oncol"},{"key":"2025112318515429600_bnaf025-B71","volume-title":"Endotext [Internet]","author":"Gan","year":"2000"},{"key":"2025112318515429600_bnaf025-B72","doi-asserted-by":"crossref","first-page":"e28723","DOI":"10.1002\/pbc.28723","article-title":"Clinical impact of hypothalamic-pituitary disorders after conformal radiation therapy for pediatric low-grade glioma or ependymoma","volume":"67","author":"van Iersel","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2025112318515429600_bnaf025-B73","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"2025112318515429600_bnaf025-B74","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in banbury (oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2025112318515429600_bnaf025-B75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00431-017-3042-5","article-title":"Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis","volume":"177","author":"Hoffmann","year":"2018","journal-title":"Eur J Pediatr"},{"issue":"4","key":"2025112318515429600_bnaf025-B76","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/epi4.12989","article-title":"Surgical and radiosurgical treatment of hypothalamic hamartoma: the Italian experience between 2011 and 2021","volume":"9","author":"Rizzi","year":"2024","journal-title":"Epilepsia Open"},{"key":"2025112318515429600_bnaf025-B77","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-3-031-53578-9_4","article-title":"Multimodal approach for the treatment of Complex hypothalamic hamartomas","volume":"50","author":"Hinojosa","year":"2024","journal-title":"Adv Tech Stand Neurosurg"},{"key":"2025112318515429600_bnaf025-B78","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.wneu.2024.08.009","article-title":"Magnetic resonance-guided Laser interstitial thermal therapy in the management of hypothalamic hamartomas: a systematic review and meta-analysis","volume":"190","author":"Ahmed","year":"2024","journal-title":"World Neurosurg"},{"issue":"4","key":"2025112318515429600_bnaf025-B79","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3171\/2024.7.JNS24560","article-title":"A proposed new classification system of hypothalamic hamartomas in the era of stereotactic ablation surgery","volume":"142","author":"Shirozu","year":"2024","journal-title":"J Neurosurg"},{"issue":"11","key":"2025112318515429600_bnaf025-B80","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1210\/jc.2012-2069","article-title":"Xanthogranuloma, Rathke's cyst, and childhood craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations","volume":"97","author":"M\u00fcller","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2025112318515429600_bnaf025-B81","first-page":"100900","article-title":"Radiotherapy-induced hypothalamic-pituitary axis dysfunction in adult brain, head and neck and skull base tumor patients\u2014a systematic review and meta-analysis","volume":"51","author":"Paulissen","year":"2025","journal-title":"Clin Transl Radiat Oncol"},{"issue":"3","key":"2025112318515429600_bnaf025-B82","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10286-023-00936-y","article-title":"Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD): a collaborative review of the current understanding","volume":"33","author":"Khaytin","year":"2023","journal-title":"Clin Auton Res"},{"issue":"7","key":"2025112318515429600_bnaf025-B83","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1210\/clinem\/dgaa247","article-title":"ROHHAD(NET) syndrome: systematic review of the clinical timeline and recommendations for diagnosis and prognosis","volume":"105","author":"Harvengt","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025112318515429600_bnaf025-B84","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000499163","article-title":"Anti-hypothalamus and anti-pituitary auto\u00adantibodies in ROHHAD syndrome: additional evidence supporting an autoimmune etiopathogenesis","volume":"92","author":"Giacomozzi","year":"2019","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"2025112318515429600_bnaf025-B85","doi-asserted-by":"crossref","first-page":"e200276","DOI":"10.1212\/NXI.0000000000200276","article-title":"Antibodies against ZSCAN1 in pediatric and adult patients with non-paraneoplastic ROHHAD syndrome","volume":"11","author":"Serafim","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"2025112318515429600_bnaf025-B86","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jpeds.2005.07.031","article-title":"Geographical distribution of optic nerve hypoplasia and septo-optic dysplasia in northwest England","volume":"148","author":"Patel","year":"2006","journal-title":"J Pediatr"},{"issue":"4","key":"2025112318515429600_bnaf025-B87","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ejhg.2009.125","article-title":"Septo-optic dysplasia","volume":"18","author":"Webb","year":"2010","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"2025112318515429600_bnaf025-B88","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1210\/jc.2006-1609","article-title":"HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism","volume":"92","author":"McNay","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025112318515429600_bnaf025-B89","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/cen.12565","article-title":"Sonic hedgehog mutations are not a common cause of congenital hypopituitarism in the absence of complex midline cerebral defects","volume":"82","author":"Paulo","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025112318515429600_bnaf025-B90","doi-asserted-by":"crossref","first-page":"100224","DOI":"10.1016\/j.eclinm.2019.11.017","article-title":"Endocrine morbidity in midline brain defects: differences between septo-optic dysplasia and related disorders","volume":"19","author":"Cerbone","year":"2020","journal-title":"EClinicalMedicine"},{"key":"2025112318515429600_bnaf025-B91","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mce.2015.09.010","article-title":"Novel application of luciferase assay for the in vitro functional assessment of KAL1 variants in three females with septo-optic dysplasia (SOD)","volume":"417","author":"McCabe","year":"2015","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"2025112318515429600_bnaf025-B92","doi-asserted-by":"crossref","first-page":"E1709","DOI":"10.1210\/jc.2011-0454","article-title":"Novel FGF8 mutations associated with recessive holoprosencephaly, craniofacial defects, and hypothalamo-pituitary dysfunction","volume":"96","author":"McCabe","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025112318515429600_bnaf025-B93","doi-asserted-by":"crossref","first-page":"E547","DOI":"10.1210\/jc.2012-3067","article-title":"Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia","volume":"98","author":"McCabe","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025112318515429600_bnaf025-B94","doi-asserted-by":"crossref","first-page":"E548","DOI":"10.1073\/pnas.1503346113","article-title":"Transcription factor 7-like 1 is involved in hypothalamo\u2013pituitary axis development in mice and humans","volume":"113","author":"Gaston-Massuet","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2025112318515429600_bnaf025-B95","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/477","article-title":"Mutations in the homeobox gene HESX1\/hesx1 associated with septo-optic dysplasia in human and mouse","volume":"19","author":"Dattani","year":"1998","journal-title":"Nat Genet"},{"key":"2025112318515429600_bnaf025-B96","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/dmcn.16235","article-title":"Morbidities and comorbidities associated with optic nerve hypoplasia and septo-optic-pituitary dysplasia","volume":"67","author":"Salman","year":"2025","journal-title":"Dev Med Child Neurol"},{"issue":"9","key":"2025112318515429600_bnaf025-B97","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1515\/JPEM.2005.18.9.853","article-title":"Hypopituitarism and neurodevelopmental abnormalities in relation to central nervous system structural defects in children with optic nerve hypoplasia","volume":"18","author":"Haddad","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"11","key":"2025112318515429600_bnaf025-B98","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1177\/08830738060210111701","article-title":"Systemic and ocular findings in 100 patients with optic nerve hypoplasia","volume":"21","author":"Lourdes Garcia","year":"2006","journal-title":"J Child Neurol"},{"issue":"10","key":"2025112318515429600_bnaf025-B99","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1469-8749.2010.03664.x","article-title":"Social communication difficulties and autism spectrum disorder in young children with optic nerve hypoplasia and\/or septo-optic dysplasia","volume":"52","author":"Parr","year":"2010","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"2025112318515429600_bnaf025-B100","doi-asserted-by":"crossref","first-page":"101371","DOI":"10.1016\/j.beem.2019.101371","article-title":"Hypophysitis: an update on the novel forms, diagnosis and management of disorders of pituitary inflammation","volume":"33","author":"Gubbi","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"2025112318515429600_bnaf025-B101","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11154-018-9480-1","article-title":"Primary hypophysitis and other autoimmune disorders of the sellar and suprasellar regions","volume":"19","author":"Gubbi","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"2025112318515429600_bnaf025-B102","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF03347301","article-title":"Lymphocytic hypophysitis in a patient with Graves\u2019 disease","volume":"21","author":"Bayram","year":"1998","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2025112318515429600_bnaf025-B103","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/eje.0.1490363","article-title":"Lymphocytic hypophysitis: a rare or underestimated disease?","volume":"149","author":"Bellastella","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2025112318515429600_bnaf025-B104","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.autrev.2008.04.016","article-title":"Pituitary autoimmunity: 30 years later","volume":"7","author":"Caturegli","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"5","key":"2025112318515429600_bnaf025-B105","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1210\/jcem.86.5.7440","article-title":"Distinct radiological and clinical appearance of lymphocytic hypophysitis","volume":"86","author":"Unl\u00fchizarci","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2025112318515429600_bnaf025-B106","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejca.2018.09.016","article-title":"Hypothalamitis and severe hypothalamic dysfunction associated with anti\u2013programmed cell death ligand 1 antibody treatment","volume":"104","author":"Tshuma","year":"2018","journal-title":"Eur J Cancer"},{"key":"2025112318515429600_bnaf025-B107","doi-asserted-by":"crossref","first-page":"1036.e5","DOI":"10.1016\/j.wneu.2017.06.055","article-title":"Long-standing isolated autoimmune hypothalamitis diagnosed with endoscopic transventricular biopsy","volume":"105","author":"Bertulli","year":"2017","journal-title":"World Neurosurg"},{"issue":"3","key":"2025112318515429600_bnaf025-B108","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/EJE-15-0422","article-title":"Nonalcoholic fatty liver disease and fatigue in long-term survivors of childhood-onset craniopharyngioma","volume":"173","author":"Hoffmann","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025112318515429600_bnaf025-B109","first-page":"583","article-title":"Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness","volume":"17","author":"M\u00fcller","year":"2006","journal-title":"Cancer Causes Control"},{"issue":"06","key":"2025112318515429600_bnaf025-B110","first-page":"423","article-title":"Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese patients with childhood craniopharyngioma","volume":"37","author":"Gebhardt","year":"2006","journal-title":"Neuropediatrics"},{"issue":"1","key":"2025112318515429600_bnaf025-B111","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/EJE-11-0158","article-title":"Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up","volume":"165","author":"M\u00fcller","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2025112318515429600_bnaf025-B112","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1093\/neuonc\/noad112","article-title":"Treatment and outcome of the Dutch childhood craniopharyngioma cohort study; first results after centralization of care","volume":"25","author":"Van Schaik","year":"2023","journal-title":"Neuro Oncol"},{"key":"2025112318515429600_bnaf025-B113","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000515318","article-title":"Hypothalamic-pituitary outcome after treatment for childhood craniopharyngioma","volume":"54","author":"van Schaik","year":"2021","journal-title":"Front Horm Res"},{"issue":"8","key":"2025112318515429600_bnaf025-B114","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.clnu.2024.05.028","article-title":"Feasibility, safety, and efficacy of dietary or lifestyle interventions for hypothalamic obesity: a systematic review","volume":"43","author":"Van Roessel","year":"2024","journal-title":"Clinical Nutrition"},{"issue":"1-2","key":"2025112318515429600_bnaf025-B115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/jpem-2014-0338","article-title":"Hypothalamic obesity after treatment for craniopharyngioma: the importance of the home environment","volume":"28","author":"Meijneke","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"8","key":"2025112318515429600_bnaf025-B116","doi-asserted-by":"crossref","first-page":"e240126","DOI":"10.1530\/EC-24-0126","article-title":"Impact of parental body mass index at diagnosis on obesity in survivors of pediatric craniopharyngioma","volume":"13","author":"Beckhaus","year":"2024","journal-title":"Endocr Connect"},{"issue":"1","key":"2025112318515429600_bnaf025-B117","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1210\/clinem\/dgad488","article-title":"Caregiver burden and its relationship to health-related quality of life in craniopharyngioma survivors","volume":"109","author":"Kayadjanian","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2025112318515429600_bnaf025-B118","doi-asserted-by":"crossref","first-page":"846880","DOI":"10.3389\/fendo.2022.846880","article-title":"Treatment of acquired hypothalamic obesity: now and the future","volume":"13","author":"Dimitri","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025112318515429600_bnaf025-B119","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s11102-024-01429-5","article-title":"Semaglutide treatment of hypothalamic obesity\u2014a real-life data study","volume":"27","author":"Svendstrup","year":"2024","journal-title":"Pituitary"},{"issue":"3","key":"2025112318515429600_bnaf025-B120","doi-asserted-by":"crossref","first-page":"e12642","DOI":"10.1111\/cob.12642","article-title":"The role of glucagon-like peptide 1 receptor agonists for weight control in individuals with acquired hypothalamic obesity\u2014a systematic review","volume":"14","author":"Ng","year":"2024","journal-title":"Clin Obes"},{"issue":"1","key":"2025112318515429600_bnaf025-B121","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000495851","article-title":"Treatment of hypothalamic obesity with dextroamphetamine: a case series","volume":"12","author":"Denzer","year":"2019","journal-title":"Obes Facts"},{"key":"2025112318515429600_bnaf025-B122","doi-asserted-by":"crossref","first-page":"845937","DOI":"10.3389\/fendo.2022.845937","article-title":"Dextroamphetamine treatment in children with hypothalamic obesity","volume":"13","author":"van Schaik","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2025112318515429600_bnaf025-B123","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MED.0000000000000798","article-title":"Setmelanotide: a promising advancement for pediatric patients with rare forms of genetic obesity","volume":"30","author":"Trapp","year":"2023","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"6","key":"2025112318515429600_bnaf025-B124","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S2213-8587(24)00087-1","article-title":"Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial","volume":"12","author":"Roth","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025112318515429600_bnaf025-B125"},{"issue":"1-2","key":"2025112318515429600_bnaf025-B126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/jpem-2014-0425","article-title":"Carbohydrate-lipid profile and use of metformin with micronized fenofibrate in reducing metabolic consequences of craniopharyngioma treatment in children: single institution experience","volume":"28","author":"Kalina","year":"2014","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"2025112318515429600_bnaf025-B127","doi-asserted-by":"crossref","first-page":"417949","DOI":"10.1155\/2011\/417949","article-title":"Hypothalamic obesity following craniopharyngioma surgery: results of a pilot trial of combined diazoxide and metformin therapy","volume":"2011","author":"Hamilton","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"issue":"6","key":"2025112318515429600_bnaf025-B128","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-21-0972","article-title":"Randomized controlled trial of tesomet for weight loss in hypothalamic obesity","volume":"186","author":"Huynh","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2025112318515429600_bnaf025-B129","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0022-3476(99)70017-X","article-title":"Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist","volume":"135","author":"Lustig","year":"1999","journal-title":"J Pediatr"},{"issue":"2","key":"2025112318515429600_bnaf025-B130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.ijo.0803074","article-title":"A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion","volume":"30","author":"Lustig","year":"2006","journal-title":"Int J Obes"},{"issue":"6","key":"2025112318515429600_bnaf025-B131","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1210\/jc.2002-030003","article-title":"Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial","volume":"88","author":"Lustig","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025112318515429600_bnaf025-B132","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/dom.13910","article-title":"A randomized, double-blind, placebo-controlled, pharmacokinetic and pharmacodynamic study of a fixed-dose combination of phentermine\/topiramate in adolescents with obesity","volume":"22","author":"Hsia","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"2025112318515429600_bnaf025-B133","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/oby.2011.330","article-title":"Controlled-release phentermine\/topiramate in severely obese adults: a randomized controlled trial (EQUIP)","volume":"20","author":"Allison","year":"2012","journal-title":"Obesity"},{"key":"2025112318515429600_bnaf025-B134","doi-asserted-by":"crossref","first-page":"1256514","DOI":"10.3389\/fendo.2023.1256514","article-title":"Treatment of hypothalamic obesity in people with hypothalamic injury: new drugs are on the horizon","volume":"14","author":"Roth","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2025112318515429600_bnaf025-B135","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/dom.14224","article-title":"A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide-1 receptor agonist in adolescents and young adults with hypothalamic obesity","volume":"23","author":"Roth","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"2025112318515429600_bnaf025-B136","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s11102-024-01426-8","article-title":"Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma","volume":"27","author":"Gjersdal","year":"2024","journal-title":"Pituitary"},{"issue":"6","key":"2025112318515429600_bnaf025-B137","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4158\/EP.14.6.697","article-title":"Treatment of hypothalamic obesity with caffeine and ephedrine","volume":"14","author":"Greenway","year":"2008","journal-title":"Endocr Pract"},{"key":"2025112318515429600_bnaf025-B138","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fendo.2011.00078","article-title":"Effects of methylphenidate on weight gain and food intake in hypothalamic obesity","volume":"2","author":"Elfers","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2025112318515429600_bnaf025-B139","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2176\/nmc.41.210","article-title":"Mazindol administration improved hyperphagia after surgery for craniopharyngioma. Case report","volume":"41","author":"Sadatomo","year":"2001","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"11","key":"2025112318515429600_bnaf025-B140","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1210\/jc.2007-0826","article-title":"Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes","volume":"92","author":"Danielsson","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025112318515429600_bnaf025-B141","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/MED.0000000000000587","article-title":"Pharmacotherapy in pediatric obesity: current evidence and landscape","volume":"28","author":"Singhal","year":"2021","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"4","key":"2025112318515429600_bnaf025-B142","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1203\/pdr.0b013e3180332cd6","article-title":"Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma","volume":"61","author":"Roth","year":"2007","journal-title":"Pediatr Res"},{"issue":"6","key":"2025112318515429600_bnaf025-B143","doi-asserted-by":"crossref","first-page":"802","DOI":"10.4093\/dmj.2020.0258","article-title":"Comprehensive review of current and upcoming anti-obesity drugs","volume":"44","author":"Son","year":"2020","journal-title":"Diabetes Metab J"},{"issue":"9","key":"2025112318515429600_bnaf025-B144","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/archpedi.156.9.887","article-title":"The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma","volume":"156","author":"Mason","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"2025112318515429600_bnaf025-B145","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-020-03519-3","article-title":"Predictors of narcolepsy and hypersomnia due to medical disorder in pediatric craniopharyngioma","volume":"148","author":"Mandrell","year":"2020","journal-title":"J Neurooncol"},{"issue":"7","key":"2025112318515429600_bnaf025-B146","doi-asserted-by":"crossref","first-page":"e28379","DOI":"10.1002\/pbc.28379","article-title":"Methylphenidate improves weight control in childhood brain tumor survivors with hypothalamic obesity","volume":"67","author":"Horne","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"1-3","key":"2025112318515429600_bnaf025-B147","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejphar.2010.03.026","article-title":"The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: comparison to sibutramine and rimonabant","volume":"636","author":"Hansen","year":"2010","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"2025112318515429600_bnaf025-B148","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/npp.2010.16","article-title":"Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of \u03b11 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat","volume":"35","author":"Axel","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"2025112318515429600_bnaf025-B149","first-page":"17-0018","article-title":"Anorexia-cachexia syndrome-like hypothalamic neuroendocrine dysfunction in a patient with a papillary craniopharyngioma","volume":"2017","author":"Balc\u00e1zar-Hern\u00e1ndez","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"11","key":"2025112318515429600_bnaf025-B150","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1210\/jc.2014-1680","article-title":"Diencephalic syndrome in childhood craniopharyngioma\u2014results of German multicenter studies on 485 long-term survivors of childhood craniopharyngioma","volume":"99","author":"Hoffmann","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025112318515429600_bnaf025-B151","doi-asserted-by":"crossref","first-page":"R175","DOI":"10.1530\/EC-21-0111","article-title":"Appetite- and weight-inducing and -inhibiting neuroendocrine factors in prader-willi syndrome, bardet-biedl syndrome and craniopharyngioma versus anorexia nervosa","volume":"10","author":"Vlaardingerbroek","year":"2021","journal-title":"Endocr Connect"},{"issue":"6","key":"2025112318515429600_bnaf025-B152","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/s-2007-985848","article-title":"First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity","volume":"219","author":"M\u00fcller","year":"2007","journal-title":"Klin Padiatr"},{"issue":"6","key":"2025112318515429600_bnaf025-B153","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1210\/jc.2012-4184","article-title":"Bariatric surgery following treatment for craniopharyngioma: a systematic review and individual-level data meta-analysis","volume":"98","author":"Bretault","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025112318515429600_bnaf025-B154","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1210\/clinem\/dgab567","article-title":"Bariatric interventions in craniopharyngioma patients\u2014best choice or last option for treatment of hypothalamic obesity?","volume":"107","author":"M\u00fcller","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025112318515429600_bnaf025-B155","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2016-2573","article-title":"Pediatric obesity\u2014assessment, treatment, and prevention: an endocrine society clinical practice guideline","volume":"102","author":"Styne","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025112318515429600_bnaf025-B156","doi-asserted-by":"crossref","first-page":"e14411","DOI":"10.1016\/j.heliyon.2023.e14411","article-title":"Could deep brain stimulation be a possible solution for acquired hypothalamic obesity?","volume":"9","author":"Dassen","year":"2023","journal-title":"Heliyon"},{"issue":"3","key":"2025112318515429600_bnaf025-B157","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pjnns.2016.01.014","article-title":"Nucleus accumbens stimulation in pathological obesity","volume":"50","author":"Harat","year":"2016","journal-title":"Neurol Neurochir Pol"},{"key":"2025112318515429600_bnaf025-B158","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fendo.2011.00060","article-title":"Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment","volume":"2","author":"Lustig","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2025112318515429600_bnaf025-B159","doi-asserted-by":"crossref","first-page":"bvad037","DOI":"10.1210\/jendso\/bvad037","article-title":"A pilot randomized clinical trial of intranasal oxytocin to promote weight loss in individuals with hypothalamic obesity","volume":"7","author":"McCormack","year":"2023","journal-title":"J Endocr Soc"},{"issue":"9","key":"2025112318515429600_bnaf025-B160","doi-asserted-by":"crossref","first-page":"e12527","DOI":"10.1111\/ijpo.12527","article-title":"Eating behaviour and oxytocin in patients with childhood-onset craniopharyngioma and different grades of hypothalamic involvement","volume":"14","author":"Daubenb\u00fcchel","year":"2019","journal-title":"Pediatr Obes"},{"issue":"2","key":"2025112318515429600_bnaf025-B161","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s12020-016-1084-5","article-title":"Oxytocin in survivors of childhood-onset craniopharyngioma","volume":"54","author":"Daubenb\u00fcchel","year":"2016","journal-title":"Endocrine"},{"issue":"1","key":"2025112318515429600_bnaf025-B162","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12020-017-1257-x","article-title":"First experiences with neuropsychological effects of oxytocin administration in childhood-onset craniopharyngioma","volume":"56","author":"Hoffmann","year":"2017","journal-title":"Endocrine"},{"issue":"2","key":"2025112318515429600_bnaf025-B163","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s12020-017-1489-9","article-title":"Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007","volume":"59","author":"Heinks","year":"2018","journal-title":"Endocrine"},{"issue":"5","key":"2025112318515429600_bnaf025-B164","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/EJE-18-0505","article-title":"Long-term effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: results of the German Craniopharyngioma Registry (HIT-Endo)","volume":"179","author":"Boekhoff","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2025112318515429600_bnaf025-B165","doi-asserted-by":"crossref","first-page":"P35","DOI":"10.1530\/EJE-21-1186","article-title":"Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement","volume":"186","author":"Boguszewski","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2025112318515429600_bnaf025-B166","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000486033","article-title":"Low FT4 concentrations around the start of recombinant human growth hormone treatment: predictor of congenital structural hypothalamic-pituitary abnormalities?","volume":"89","author":"Van Iersel","year":"2018","journal-title":"Horm Res Paediatr"},{"issue":"12","key":"2025112318515429600_bnaf025-B167","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1530\/EC-18-0311","article-title":"Declining free thyroxine levels over time in irradiated childhood brain tumor survivors","volume":"7","author":"van Iersel","year":"2018","journal-title":"Endocr Connect"},{"key":"2025112318515429600_bnaf025-B168","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1210\/endrev\/bnab040","article-title":"Hypothalamic-pituitary and other endocrine surveillance among childhood cancer survivors","volume":"43","author":"van Iersel","year":"2021","journal-title":"Endocr Rev"},{"issue":"11","key":"2025112318515429600_bnaf025-B169","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1210\/jc.2019-00539","article-title":"Clinical importance of free thyroxine concentration decline after radiotherapy for pediatric and adolescent brain tumors","volume":"104","author":"Van Iersel","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2025112318515429600_bnaf025-B170","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2025112318515429600_bnaf025-B171","doi-asserted-by":"crossref","first-page":"737743","DOI":"10.3389\/fneur.2021.737743","article-title":"Endocrine disorder in patients with craniopharyngioma","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Neurol"},{"issue":"1","key":"2025112318515429600_bnaf025-B172","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/jc.2002-020511","article-title":"11 beta-hydroxysteroid dehydrogenase activity in hypothalamic obesity","volume":"88","author":"Tiosano","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"9-10","key":"2025112318515429600_bnaf025-B173","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1159\/000515347","article-title":"Postoperative and long-term endocrinologic complications of craniopharyngioma","volume":"93","author":"Bereket","year":"2020","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"2025112318515429600_bnaf025-B174","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3122\/jabfm.2024.240025R1","article-title":"Benefits of testosterone replacement therapy in hypogonadal males","volume":"37","author":"Blackwell","year":"2024","journal-title":"J Am Board Fam Med"},{"key":"2025112318515429600_bnaf025-B175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pcad.2024.04.001","article-title":"Association between testosterone replacement therapy and cardiovascular outcomes: a meta-analysis of 30 randomized controlled trials","volume":"85","author":"Jaiswal","year":"2024","journal-title":"Prog Cardiovasc Dis"},{"issue":"6","key":"2025112318515429600_bnaf025-B176","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1093\/ejendo\/lvae128","article-title":"Mechanisms in endocrinology: hypogonadism and metabolic health in men\u2014novel insights into pathophysiology","volume":"191","author":"Miller","year":"2024","journal-title":"Eur J Endocrinol"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/edrv\/advance-article-pdf\/doi\/10.1210\/endrev\/bnaf025\/63904548\/bnaf025.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/article-pdf\/46\/6\/891\/63904548\/bnaf025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/article-pdf\/46\/6\/891\/63904548\/bnaf025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T23:52:37Z","timestamp":1763941957000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/46\/6\/891\/8220566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":176,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,8,1]]},"published-print":{"date-parts":[[2025,11,24]]}},"URL":"https:\/\/doi.org\/10.1210\/endrev\/bnaf025","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,8,1]]}}}